T Vertex - Search News

FDA, Vertex

Hosted on MSN · 1d

Vertex Pharmaceuticals Stock Jumps After FDA Approval for New Non-Opioid Painkiller

Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more than 20 years.

Washington Examiner · 2h

FDA approves painkiller designed to eliminate the risk of addiction associated with opioids

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.

FiercePharma · 1d

Vertex scores FDA nod for long-awaited non-opioid pain reliever Journavx

Vertex has gained the FDA's approval for its nonaddictive pain med Journavx, which becomes the first significant innovation in pain relief in more than two decades.

2don MSN

Jim Cramer on Vertex Pharmaceuticals Incorporated (VRTX)’s Suzetrigine: ‘I Don’t See A Lot Of Upside Because That Was The Drug Of The Future For Vertex’

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...

11d

Vertex: Risky Valuation Amid Shaky Organic Growth

Vertex specializes in corporate tax compliance software, targeting a $22B global TAM with a focus on enterprise and SMB ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results